Previous 10 | Next 10 |
Bioceres Crop Solutions Corp. (“Bioceres”) (NYSE American: BIOX) , a fully integrated provider of crop productivity solutions, today announced Financial Officer Enrique Lopez Lecube will be presenting at this year’s Fall Investor Summit taking place on September 16 th a...
Bioceres Crop Solutions Corp. (“Bioceres”) (NYSE American: BIOX) , a fully integrated provider of crop productivity solutions, today announced that it plans to report its Fourth Quarter and Fiscal Year 2019 results on Friday, September 13, 2019 after the close of the New York S...
Arcadia Biosciences, Inc. ( RKDA ) closed up 124% to $4.51 on Friday after announcing that its subsidiary Verdeca received approval from the U.S. Department of Agriculture for its HB4® drought tolerant soybeans. Along with the FDA approval in 2017, this clears the way for commercializat...
Thinly traded nano cap Arcadia Biosciences (NASDAQ: RKDA ) is up 60% premarket on robust volume in reaction to its announcement that the USDA has approved Verdeca's HB4 drought-tolerant soybeans, clearing the way for commercialization in the U.S. (the FDA signed off on HB4 two ...
With USDA decision, HB4 ® event achieves regulatory approvals for more than 80 percent of the global soybean market Bioceres Crop Solutions Corp . (NYSE American: BIOX), announced today that Verdeca , a joint venture between BCS Holding Inc., a wholly owned subsidiary of ...
Adjusted EBITDA for the nine-month period ended March 31, 2019 increased by 94%. Management expects to exceed guidance of $38 million for fiscal year ending June 30, 2019. Over $35 million in debt recently termed-out through multiple agreements. Bioceres Crop Solutions Corp...
Please replace the first paragraph of the release with the following corrected version due to multiple revisions. The corrected release reads: BIOCERES CROP SOLUTIONS CORP. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF ENDED DECEMBER 31, 2018 On March 14, 2019...
Quick Take Bioceres ( BIOX ) intends to raise $100 million in a U.S. IPO, according to a new F-1/A registration statement . The agricultural technology firm previously attempted to go public earlier in 2018 with a $130 million offering. BIOX is attempting to IPO for the third time i...
Market volatility was back this week, and IPOs either dropped out or dropped their valuations. Six companies in five different sectors raised a combined $992 million, along with one SPAC. Four of the six deals priced below the midpoint of the range, and five broke their issue price during earl...
Bioceres has chosen to delay its IPO (pending ticker BIOX) for a second straight day. Reuters reported that the Argentine agricultural company was supposed to go public on Tuesday, the company has delayed its unveiling by one day on Wednesday, and then announced again that it would be delaye...
News, Short Squeeze, Breakout and More Instantly...
Bioceres Crop Solutions Corp. Company Name:
BIOX Stock Symbol:
NASDAQ Market:
Bioceres Crop Solutions Corp. Website:
2024-06-20 03:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-10 04:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Total revenues in 3Q24 were $84.0 million 3Q24 GAAP net income was $9.8 million and adjusted EBITDA 1 was $21.1 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX) , a leader in the development and commercialization of productivity solutions designed ...